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Recognition of the role of Helicobacter pylori gastric infection 
in human disease has dramatically changed the management 
of peptic ulceration, and the Nobel honours bestowed on 
Marshall and Warren in 2005 in acknowledgement of their 
landmark research has focused public attention on this 
organism.1-3 Furthermore, the neoplastic potential of H. pylori, 
which is defined as a type 1 carcinogen, is well recognised 
and has resulted in some advocating the widespread, 
worldwide eradication of this infection.2,4,5 A diagnosis of H. 
pylori infection is readily made using non-invasive tests, such 
as 13C and 14C urea breath testing, stool antigen analysis or 
H. pylori serology. Alternatively, infection can be detected in 
gastric biopsies obtained at endoscopy, through histological 
staining, tissue culture or polymerase chain reaction (PCR). Far 
simpler, however, is to diagnose the bacterium by detecting the 
presence of an H. pylori-derived enzyme, urease, within gastric 
biopsies. The urease-driven production of ammonia, when 
H. pylori-infected gastric tissue is added to a urea-containing 
medium, elicits a pH-dependent colour change that forms the 
essence of this diagnostic test.5-8 Many versions of the ‘urease 
test’ have been developed, with varying reported sensitivities 
and specificities. A locally produced adaptation, the rapid 
urease test ((RUT), National Health Laboratory Services, Cape 
Town), is used at Groote Schuur Hospital and some centres 
across South Africa. The RUT is inexpensive (R4.40 per bottle 
excluding value added tax) and easy to perform; however, 
this in-house method has never previously been validated. In 
addition, while not evidence based, it is common practice in 
our clinic to use a single biopsy of the gastric antrum for this 
investigation and to analyse colour change within 5 minutes of 
RUT commencement and determine the need for eradication 
therapy based on this result. Other commercially available 
RUTs are read at 24 hours.
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Background. The rapid urease test (RUT) is used at Groote 
Schuur Hospital for diagnosing Helicobacter pylori infection. 
This is an in-house method, which has not been validated.
Objective. To validate our practice of reading the RUT 
immediately after endoscopy (RUT0), by comparing this with a 
reading at 24 hours (RUT24) and with histological analysis. 
Design. Ninety consecutive patients undergoing upper 
endoscopy over a 6-week period from October 2005 to 
November 2005, and in whom rapid urease testing was 
indicated, were included in the study. Patients with recent 
exposure (within 2 weeks of endoscopy) to proton pump 
inhibitors (PPIs), histamine receptor antagonists (H2RAs) 
and antibiotics (confounders) were noted and included in 
the cohort. Two antral and two body biopsies were taken 
for histological examination and a third antral biopsy was 
placed in the RUT bottle. Both haematoxylin and eosin and 
modified Giemsa staining methods were used to identify 
H. pylori. The RUT was read immediately (within 5 minutes 
of upper endoscopy) (RUT0), as per our current practice, and 
each specimen was re-read at 24 hours (RUT24). Sensitivity, 
specificity, positive and negative predictive values and the 
impact of confounders were calculated.
Results. Of the 90 patients undergoing rapid urease testing, 
39% were male and 61% were female, with a mean age of 55 
years (range 22 - 79 years). Histological examination revealed 
H. pylori in 67.8% (N=61) of the biopsy specimens. In the 65 
patients without confounders, the sensitivity and specificity 
of the RUT0 were 65.9% and 100% respectively, and 90.9% 
and 100% for RUT24. After including the 25 patients with 
confounders, the sensitivity and specificity were 68.8% and 
100% for RUT0, and 90.1% and 100% for RUT24 respectively. 
Thirteen RUT0 specimens (30.9%) that were initially negative 
became positive at the RUT24 reading. There were 6 (9.8%) 
RUT0- and RUT24-negative but histology-positive specimens. 
Four of these 6 false-negative RUT24 results could be accounted 
for by a low H. pylori density on histological analysis (2 
patients were taking PPIs). Confounders did not alter the 
sensitivity and specificity outcomes or impact on the number 
of false-negative RUTs. 
Conclusions. Our locally prepared RUT is a specific test for 
the detection of H. pylori infection. The sensitivity is greatly 
enhanced by reading the test at 24 hours. The use of PPIs, 
H2RAs and antibiotics preceding endoscopy did not impact 
significantly on the results. 
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The aim of this study was therefore to determine the 
validity of our current practice of reading the RUT early after 
endoscopy (at 5 minutes, RUT0), by comparing this with a 
reading at 24 hours (RUT24) and with histological examination. 
Patients and methods
Patients 
Ninety consecutive subjects undergoing upper gastrointestinal 
endoscopy over a 6-week period (1 October 2005 - 14 
November 2005) in whom rapid urease testing was indicated 
based on standard clinical or endoscopic criteria, were included 
in the study. Patients with actively bleeding peptic ulcer 
disease were excluded, as this is a well-recognised cause of a 
false-negative urease test.9 
Patient demographics were determined at the endoscopy 
visit. Recent medication use, in particular exposure within 
2 weeks of endoscopy to proton pump inhibitors (PPIs), 
histamine-2 receptor antagonists (H2RAs) or antibiotics, was 
recorded and defined as study confounders (use of these 
agents suppresses H. pylori infection).10 Subjects with exposure 
to these drugs were included and analysed separately. 
Diagnostic methods
Five gastric biopsies were taken during endoscopy. Four 
specimens, of which 2 were taken from the antrum within 3 cm 
of the pylorus and 2 from the body, were fixed with formalin 
and embedded in paraffin. Both haematoxylin and eosin and 
modified Giemsa staining methods were used for histological 
identification of H. pylori. Our in-house pathologists, who have 
experience with this technique, carried out the histological 
assessment. The accepted gold standard for histological 
diagnosis of H. pylori infection is 2 antral biopsies taken 
within 3 cm of the pylorus and evaluated by an experienced 
pathologist using the appropriate special stains.11 The fifth 
biopsy specimen, also taken from the antrum, was placed in 
the RUT bottle (National Health Laboratory Services, Cape 
Town). The ingredients of this in-house medium comprised a 
10% urea solution (30 g urea and 300 ml de-ionised water) and 
1% phenol red solution (1 g phenol red and 100 ml de-ionised 
water). In the presence of the H. pylori urease, urea is converted 
into ammonium and carbon dioxide triggering an alteration in 
pH. This results in a change from yellow to purple/magenta 
and denotes a positive test. 
The RUT was read immediately (within 5 minutes of upper 
endoscopy, RUT0), as per our current practice, and each 
specimen (stored at room temperature) was re-read at 24 hours 
(RUT24).
Statistical analysis
The chi-square test or Fisher’s exact test was used as 
appropriate to compare percentages. Estimates of sensitivity, 
specificity, as well as positive and negative predictive values, 
were calculated in the usual manner. Statistical analysis was 
performed using the computer software Medicalc (version 
7.5, 2004, Medcalc Software, Belgium). Statistical tests were 
performed at the 5% level of significance.
This study was approved by the University of Cape Town 
Ethical Committee.
Results
Of the 90 patients undergoing rapid urease testing, 39% were 
male and 61% female, with a mean age (± standard deviation 
(SD)) of 55±14.9 years (range 22 - 79 years).  
Overall, 61 patients (67.8%) had histological evidence of 
H. pylori infection on light microscopy (Table I). Of these, 
42 patients (68.8%) were RUT0-positive and 55 (90.1%) were 
RUT24-positive. Thirteen (30.9%) RUT0 specimens that were 
initially negative became positive at the RUT24 reading. Six 
patients (9.8%) had false-negative RUTs at 24 hours, with 
confirmed evidence of H. pylori on histological analysis. No 
false-positive RUTs were detected.
Of the 90 patients in total, the sensitivity and specificity 
were 68.8% and 100% for RUT0, and 90.1% and 100% for RUT24 
respectively. The positive predictive values were 100% for both 
readings and the negative predictive values calculated were 
60.4% and 82.8% respectively (Table II).
In the group of 65 patients without confounders, 44 patients 
(67.6%) had histological evidence of H. pylori infection. 
Twenty-nine patients (65.9 %) were RUT0-positive and 40 
patients (90.9%) were RUT24-positive. Eleven (37.9%) RUT0       
specimens that were initially negative became positive at the 
RUT24 reading. Four patients (9%) had false-negative RUTs 
with evidence of H. pylori on histological analysis. Of the 65 
patients without confounders, the sensitivity and specificity of 
the RUT0 were 65.9% and 100%, and 90.9% and 100% for RUT24 
respectively (Table II). 
Twenty-five patients had received PPIs, H2RAs or antibiotics 
(confounders) within 2 weeks of undergoing endoscopy. Of 
these, 17 patients (68%) had histological evidence of H. pylori 
infection. Thirteen patients (76.5%) were RUT0-positive and 15 
patients (88.2%) were RUT24-positive. Two specimens (15.3%) 
that were initially negative became positive at the RUT24 
reading. Two patients (11.7%) had false-negative RUTs with 
evidence of H. pylori infection on histological analysis. In the 
Table I. Patient demographics (N=90)
Age (years) (mean±SD, range)  55±14.9
     22 - 79
Gender (N (%))
Male     35 (39)
Female     55 (61)
H. pylori gastritis on histological 
analysis (N (%))    61 (67.8)
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25 patients with confounders the sensitivity and specificity of 
the RUT0 were 76.5% and 100% and 88.2% and 100% for RUT24 
respectively (Table II).
On further analysis, the use of PPIs, H2RAs or antibiotics 
did not alter the sensitivity and specificity outcomes, or impact 
significantly on the number of false-negative RUT24  results 
when compared with histologically proven H. pylori (p=1). 
Discussion
Almost 70% of the patients in this study had histological 
evidence of H. pylori infection; this is in keeping with similar 
data from South Africa and other countries in Africa.12-13 
Given the gastroduodenal pathology associated with H. pylori 
infection, a rapid, safe and inexpensive test that has a high 
specificity and sensitivity is critical in our environment. The 
in-house RUT solution compares favourably with other RUTs 
for the detection of H. pylori, with an overall sensitivity and 
specificity of 90% and 100% respectively. A study comparing 
commercially available rapid urease tests, the CLO test (Delta 
West Bentley, WA, Australia), ProntoDry (Medical Instrument 
Corp., Solothurn, Switzerland) and HpONE (GI Supply, Camp 
Hill, Pa, USA) showed a sensitivity of 86.2%, 93% and 93% 
respectively.7 All three tests showed 100% specificity.7 Other 
data have found a sensitivity and specificity of 98.9% and 
91.9% respectively.8 The characteristics of these rapid urease 
tests were reported using the appropriate commercially 
validated timing of reading the respective tests. In the case of 
the CLO test (the most widely used and best studied rapid 
urease test7) the reading was done at 24 hours.
In our study 13 RUT0 specimens (30.9%) that were initially 
negative became positive at the RUT24 reading. Furthermore, 
extending the RUT time interval from within 5 minutes of 
endoscopy to 24 hours increased both the sensitivity (from 
69% to 90%) and the negative predictive value of the test 
(from 60% to 83%). This suggests that the RUT should be read 
within 5 minutes of endoscopy, and, if negative, again at 24 
hours, to ensure optimal detection of H. pylori infection. This 
characteristic has been documented previously with other 
urease tests, in particular the CLO test, which was noted to 
have a false-negative rate of approximately 40% at 3 hours.14 
We have not determined whether reading the RUT at other 
time intervals within the 24-hour period would yield an 
acceptable sensitivity.
Overall 6 specimens (9.8%) were both RUT0 and RUT24-
negative, but positive for H. pylori on histological examination. 
These cases can therefore be considered false-negatives. False-
negative urease tests have been reported in association with 
several factors. The use of acid suppression medication, in 
particular PPIs, has been shown to reduce H. pylori density and 
colonisation and suppress the urease activity of the bacterium, 
and, as such, reduce the accuracy of the test.10 Four of the 6 
subjects with false-negative RUT24  results  in this study (of 
whom 2 had recent exposure to PPIs) had very low density of 
H. pylori organisms on histological examination and, therefore, 
potentially low urease activity in the RUT solution. On 
further analysis, however, exposure to PPIs or H2RAs did not 
significantly influence the number of false-negative RUT24s, 
or alter the sensitivity and specificity outcomes. This may, 
however, represent a type 2 error as a consequence of the small 
number of false-negative RUT24s detected in the subgroup with 
confounders. 
The presence of blood in the stomach is also a well-described 
cause of false-negative urease tests.9 In this study, however, 
such subjects were excluded and this would not account for 
test inaccuracy.
Doubling the amount of tissue in the CLO test has been 
shown to hasten positivity of the test by up to 2 hours.14 In 
addition, biopsies taken from the gastric angulus maximise the 
probability of detecting H. pylori using a RUT.15
Whether taking biopsies from the gastric angulus rather 
than the antrum and increasing the number of biopsy samples 
placed in the bottle improves time to positivity and sensitivity, 
remains unanswered by this study.
Unanswered questions notwithstanding, what this study 
does highlight are the deficiencies with using an early negative 
RUT reading to determine the presence of H. pylori infection.  
However, it is comforting to know that in the resource-
conscious environment within which we practise medicine in 
South Africa, there is an inexpensive, sensitive and specific test 
that compares very favourably with the industry standard. The 
recommendation to those practitioners doing gastroscopy and 
using the RUT solution as detailed in this study, is that their 
practice should change from reading the RUT within 5 minutes 
of endoscopy to include a reading of the RUT at 24 hours, 
should the initial test be negative. 
Table II.  Performance characteristics of RUT0 and RUT24 
                  RUT0     RUT24
All patients (N=90)
H. pylori on histological analysis (N=61)
RUT-positive (N)    42 55
Sensitivity (%)    68.8 90.1
Specificity (%)    100 100
Positive predictive value (%)  100 100
Negative predictive value (%)  60.4 82.8
Excluding subjects with confounders* (N=65) 
H. pylori on histological analysis (N=44)  
Sensitivity (%)    65.9 90.9
Specificity (%)    100 100
Subjects with confounders* (N=25)
H. pylori on histological analysis (N=17)
Sensitivity (%)    76.5 88.2
Specificity (%)    100 100
*Confounders are defined as exposure to PPIs, H
2
RAs or antibiotics within 2 weeks of 
rapid urease testing.
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Screening for diabetic retinopathy in primary care with a 
mobile fundal camera – evaluation of a South African pilot 
project
Bob Mash, Di Powell, Felicity du Plessis, Unita van Vuuren, Margaret Michalowska, Naomi Levitt
Background and aims. In South Africa diabetes makes a 
significant contribution to the burden of disease. Diabetic 
retinopathy is a leading cause of adult blindness, and screening 
can reduce the incidence. This project aimed to implement 
and evaluate a new service for retinal screening that uses a 
non-mydriatic mobile fundal camera in primary care. This is 
the first time such a service has been evaluated in an African 
primary care context.
Methods. The service was implemented as an operational 
research study at three community health centres and data 
were collected to evaluate the operational issues, screening, 
reporting and referral of patients.
Results. Out of 400 patients screened 84% had a significantly 
reduced visual acuity, 63% had retinopathy (22% severe non-
proliferative, 6% proliferative and 15% maculopathy), 2% 
of eyes could not be screened and 14% of patients required 
dilatation. Referral was necessary in 27% of cases for cataracts, 
in 7% for laser treatment and in 4% for other specialist services. 
Repeat photography was needed in 8% and urgent follow-up 
in 12%.  A SWOT analysis of the pilot project was completed 
and recommendations were made on how to integrate it into 
the district health system.
Conclusion. Screening with a fundal camera improved the 
quality of care for diabetic patients and is feasible in the South 
African public sector, primary care setting. A single technician 
should be able to photograph almost 10 000 patients a year. 
S Afr Med J 2007; 97: 1284-1288.
In South Africa diabetes affects 5 - 10% of the adult 
population,1 and in Cape Town it is estimated that 25 800 
diabetic patients are known to the Metro District Health 
Services (MDHS). Out of this diabetic population 55% are 
likely to have retinopathy,2 although only 11% have their 
eyes routinely examined.3 This is of concern because diabetic 
retinopathy is a leading cause of adult blindness and a third 
of patients already have retinopathy when type 2 diabetes is 
diagnosed.4 Retinopathy is asymptomatic until an advanced 
stage, and consequently screening for its presence is essential 
in order to identify eyes that would benefit from laser 
therapy.4  Screening for retinopathy can reduce the incidence of 
blindness.4 
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